Automated cryogenic storage systems market seen hitting $4.31 billion by 2030

The automated cryogenic storage systems market is projected to grow from $2.64 billion in 2025 to $4.31 billion by 2030, driven by biobanking, pharmaceutical research and personalized medicine. North America led the market in 2025, while Asia-Pacific is forecast to grow fastest as demand rises for secure, automated sample storage.

Why it matters: - Automated cryogenic storage systems are becoming core infrastructure for biobanking, pharmaceutical research and clinical studies. - The market is expanding as labs need more secure, traceable and hands-off storage for biological samples and patient-specific materials. - Growth in personalized medicine and cell and gene therapy is increasing demand for long-term ultra-low temperature preservation.

What happened: - The Business Research Company said the global automated cryogenic storage systems market is projected to rise from $2.64 billion in 2025 to $2.92 billion in 2026. - The same report forecasts the market will reach $4.31 billion by 2030. - The report puts the 2025-2030 compound annual growth rate at 10.2%. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report is titled The Automated Cryogenic Storage Systems Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035.

The details: - Automated cryogenic storage systems use robotics, software controls and cryogenic refrigeration to preserve biological materials, chemicals and sensitive samples at extremely low temperatures. - The systems are designed to support secure storage, precise sample management and minimal human involvement. - The report links recent growth to increased biobanking activity, expanding pharmaceutical research, more clinical research, stronger demand for long-term preservation and broader adoption of laboratory automation. - The report says future growth will also come from advances in cell and gene therapy, rising precision medicine research, more investment in biorepositories, expanding regenerative medicine use and stronger demand for secure automated sample storage. - The report identifies wider adoption of high-density sample storage, automated biobank management, ultra-low temperature preservation, touch-free sample handling, and stronger sample integrity and traceability as key trends. - A free sample of the report is available through the company’s sample request page. - The full report is available at the company’s market report page.

Between the lines: - Personalized medicine is a major demand driver because it depends on storing and tracking patient-specific samples used in genomic research, biomarker identification and targeted therapies. - The Personalized Medicine Coalition reported 16 new personalized treatments were approved by the FDA in 2023 for rare disease patients, up from six in 2022. - That jump suggests the clinical pipeline for personalized therapies is widening, which increases the need for reliable sample storage systems. - North America’s lead likely reflects deeper healthcare infrastructure and stronger research capacity. - Asia-Pacific’s growth outlook points to rising healthcare technology investment and expanding pharmaceutical research across the region.

What's next: - The market’s next phase will likely center on automation, traceability and tighter sample control as research workflows become more complex. - Biorepositories and research organizations may keep investing in higher-density storage and touch-free handling systems. - Demand for automated storage should track continued growth in personalized medicine, cell therapy and regenerative medicine.

The bottom line: - Automated cryogenic storage is moving from a niche lab tool to critical research infrastructure, with double-digit growth expected through 2030.